Xcell Biosciences: Funding, Investors & Team (Oct 2026)
Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Their proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies.
Xcell Biosciences has raised $16.9M across 3 funding rounds on record, the most recent an undisclosed round of $1.4M announced in Dec 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Xcell Biosciences Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Xcell Biosciences Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Xcell Biosciences raised $15.5M in an undisclosed round announced in Sep 2021.
2.6 years later, an undisclosed round was announced in Apr 2024 with no disclosed amount.
8 months later, an undisclosed round of $1.4M was announced in Dec 2024.
Xcell Biosciences Founders and Leadership Team
Contact details for the Xcell Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Xcell Biosciences Funding Compared to Other Biotechnology Startups
Xcell Biosciences' latest round of $1.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Xcell Biosciences in Biotechnology and San Francisco
Companies Similar to Xcell Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Xcell Biosciences Funding FAQs
What does Xcell Biosciences do?
Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Their proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies.
How much funding has Xcell Biosciences raised?
Xcell Biosciences has raised $16.9M across 3 rounds on record. The most recent is an undisclosed round of $1.4M announced in Dec 2024.
When did Xcell Biosciences last raise funding?
Xcell Biosciences' most recent funding round on record is an undisclosed round of $1.4M, announced in Dec 2024.
Who founded Xcell Biosciences?
FundedIQ lists Brian Feth (Founder) at Xcell Biosciences.
Where is Xcell Biosciences headquartered?
Xcell Biosciences is based in San Francisco, California, United States.
How many employees does Xcell Biosciences have?
Xcell Biosciences is in the 11-50 employee band.
How does Xcell Biosciences' funding compare to other Biotechnology startups?
Xcell Biosciences' latest round of $1.4M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Xcell Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Xcell Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.